Share Price and Basic Stock Data
Last Updated: February 10, 2026, 8:25 pm
| PEG Ratio | 1.77 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Art Nirman Ltd operates within the project consultancy and turnkey industry, currently priced at ₹41.3 with a market capitalization of ₹103 Cr. The company has shown fluctuating revenue trends, with sales of ₹6.72 Cr in September 2022, declining to ₹1.02 Cr by December 2022, and then rebounding to ₹11.68 Cr by March 2023. The revenue peaked at ₹13.38 Cr in March 2024, before recording ₹27.39 Cr for FY 2025. The trailing twelve months (TTM) revenue stood at ₹21.67 Cr. This volatility in sales reflects the nature of the consultancy business, which can be influenced by project timelines and client demand. The operating profit margin (OPM) of 20% indicates a strong ability to manage costs relative to sales, particularly when compared to typical sector margins, which can range from 15% to 25%. Overall, Art Nirman’s revenue trajectory highlights the potential for growth, but also underscores the risks associated with project dependency.
Profitability and Efficiency Metrics
Art Nirman Ltd reported a net profit of ₹1.41 Cr, translating to a net profit margin of 7.27% for FY 2025, a significant recovery from a previous loss of ₹11 Cr in FY 2022. The return on equity (ROE) stood at 5.48%, while the return on capital employed (ROCE) was recorded at 6.63%, which are considered low compared to industry averages typically above 10%. The interest coverage ratio (ICR) of 3.26x indicates the company can comfortably meet its interest obligations, reducing financial risk. However, the cash conversion cycle (CCC) of 33.18 days suggests efficient working capital management, particularly in light of the company’s significant operational expenses. The consistency in OPM, which reached 20% in September 2025, demonstrates effective cost control. Despite these positive indicators, the low ROE and ROCE raise concerns about overall profitability and capital efficiency.
Balance Sheet Strength and Financial Ratios
As of September 2025, Art Nirman Ltd reported total borrowings of ₹19.83 Cr against reserves of ₹12.69 Cr, resulting in a debt-to-equity ratio of 0.48, which is considered manageable. The company’s current ratio stood at 5.57, indicating a strong liquidity position, well above the typical threshold of 1.5 for financial health. The book value per share was ₹14.94, reflecting a price-to-book ratio of 2.88x, which is relatively high, suggesting that the stock may be overvalued compared to its net asset value. The enterprise value of ₹121.61 Cr relative to net operating revenue of ₹27.39 Cr yields an EV/EBITDA ratio of 33.09, indicating a premium valuation in the market. Overall, while the balance sheet shows strength in liquidity and manageable leverage, concerns over valuation metrics may deter potential investors.
Shareholding Pattern and Investor Confidence
Art Nirman Ltd maintains a stable shareholding structure, with promoters holding 73.75% and the public owning 26.25%. The number of shareholders increased to 3,260 as of September 2025, indicating a growing interest in the company. This stability among promoters suggests confidence in the long-term strategy, as they have maintained their stake without dilution. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may reflect a cautious sentiment towards the stock, possibly due to its historical volatility and low profitability ratios. The lack of institutional backing could lead to increased stock price volatility, as retail investors typically have less stability. Overall, the shareholding pattern indicates a strong promoter commitment alongside potential challenges in attracting institutional investment.
Outlook, Risks, and Final Insight
The outlook for Art Nirman Ltd appears cautiously optimistic, driven by recent revenue recovery and effective cost management strategies. However, risks persist, particularly concerning project dependency and the company’s ability to maintain profitability amidst fluctuating market conditions. The low ROE and ROCE suggest that while the company can generate sales, it struggles to convert those into substantial returns on equity, which may deter long-term investors. The high price-to-book and EV/EBITDA ratios also indicate potential overvaluation risks, especially if earnings growth does not materialize as anticipated. In a positive scenario, continued project wins could enhance revenue stability and profitability, while negative outcomes may arise from project delays or market downturns, impacting cash flows and investor confidence. Thus, stakeholders should weigh these factors carefully when considering their investment strategies.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fine Line Circuits Ltd | 43.7 Cr. | 90.9 | 108/52.4 | 208 | 18.7 | 0.00 % | 4.45 % | 2.30 % | 10.0 |
| Filtra Consultants & Engineers Ltd | 72.4 Cr. | 66.0 | 92.4/53.0 | 26.1 | 22.0 | 3.03 % | 16.5 % | 11.4 % | 10.0 |
| DRA Consultants Ltd | 15.9 Cr. | 14.5 | 35.0/14.0 | 5.96 | 30.8 | 0.00 % | 11.7 % | 8.07 % | 10.0 |
| Zodiac Energy Ltd | 442 Cr. | 291 | 563/235 | 22.2 | 66.8 | 0.26 % | 20.0 % | 27.5 % | 10.0 |
| Rites Ltd | 10,965 Cr. | 228 | 316/192 | 26.6 | 54.8 | 3.31 % | 21.8 % | 14.7 % | 10.0 |
| Industry Average | 2,934.86 Cr | 383.58 | 51.91 | 123.85 | 0.65% | 12.09% | 10.71% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.72 | 1.02 | 11.68 | 5.22 | 11.95 | 3.75 | 13.38 | 5.50 | 8.46 | 4.50 | 8.92 | 1.50 | 6.75 |
| Expenses | 6.58 | 0.95 | 10.96 | 5.01 | 11.14 | 3.52 | 12.59 | 4.99 | 7.83 | 4.18 | 7.10 | 1.52 | 5.40 |
| Operating Profit | 0.14 | 0.07 | 0.72 | 0.21 | 0.81 | 0.23 | 0.79 | 0.51 | 0.63 | 0.32 | 1.82 | -0.02 | 1.35 |
| OPM % | 2.08% | 6.86% | 6.16% | 4.02% | 6.78% | 6.13% | 5.90% | 9.27% | 7.45% | 7.11% | 20.40% | -1.33% | 20.00% |
| Other Income | 0.00 | 0.00 | 0.02 | 0.16 | 0.03 | 0.02 | 0.12 | 0.08 | 0.09 | 0.14 | 0.09 | 0.12 | 0.05 |
| Interest | 0.00 | 0.00 | 0.20 | 0.01 | 0.00 | 0.00 | 0.56 | 0.02 | 0.02 | 0.02 | 1.07 | 0.03 | 0.84 |
| Depreciation | 0.18 | 0.18 | 0.18 | 0.17 | 0.17 | 0.17 | 0.16 | 0.16 | 0.16 | 0.16 | 0.09 | 0.14 | 0.12 |
| Profit before tax | -0.04 | -0.11 | 0.36 | 0.19 | 0.67 | 0.08 | 0.19 | 0.41 | 0.54 | 0.28 | 0.75 | -0.07 | 0.44 |
| Tax % | 0.00% | 0.00% | -8.33% | 0.00% | 0.00% | 0.00% | -15.79% | 0.00% | 0.00% | 0.00% | -4.00% | 0.00% | 0.00% |
| Net Profit | -0.04 | -0.11 | 0.39 | 0.19 | 0.67 | 0.08 | 0.22 | 0.41 | 0.53 | 0.28 | 0.77 | -0.07 | 0.43 |
| EPS in Rs | -0.02 | -0.04 | 0.16 | 0.08 | 0.27 | 0.03 | 0.09 | 0.16 | 0.21 | 0.11 | 0.31 | -0.03 | 0.17 |
Last Updated: January 2, 2026, 11:00 am
Below is a detailed analysis of the quarterly data for Art Nirman Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 6.75 Cr.. The value appears strong and on an upward trend. It has increased from 1.50 Cr. (Jun 2025) to 6.75 Cr., marking an increase of 5.25 Cr..
- For Expenses, as of Sep 2025, the value is 5.40 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.52 Cr. (Jun 2025) to 5.40 Cr., marking an increase of 3.88 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.35 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Jun 2025) to 1.35 Cr., marking an increase of 1.37 Cr..
- For OPM %, as of Sep 2025, the value is 20.00%. The value appears strong and on an upward trend. It has increased from -1.33% (Jun 2025) to 20.00%, marking an increase of 21.33%.
- For Other Income, as of Sep 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.12 Cr. (Jun 2025) to 0.05 Cr., marking a decrease of 0.07 Cr..
- For Interest, as of Sep 2025, the value is 0.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.03 Cr. (Jun 2025) to 0.84 Cr., marking an increase of 0.81 Cr..
- For Depreciation, as of Sep 2025, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.14 Cr. (Jun 2025) to 0.12 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.44 Cr.. The value appears strong and on an upward trend. It has increased from -0.07 Cr. (Jun 2025) to 0.44 Cr., marking an increase of 0.51 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 0.43 Cr.. The value appears strong and on an upward trend. It has increased from -0.07 Cr. (Jun 2025) to 0.43 Cr., marking an increase of 0.50 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.17. The value appears strong and on an upward trend. It has increased from -0.03 (Jun 2025) to 0.17, marking an increase of 0.20.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:38 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 24.31 | 25.46 | 34.51 | 18.89 | 62.12 | 81.13 | 36.83 | 19.72 | 34.29 | 27.39 | 21.67 |
| Expenses | -0.15 | -0.96 | 23.04 | 24.28 | 27.02 | 8.91 | 53.77 | 78.54 | 46.74 | 18.75 | 32.25 | 24.11 | 18.20 |
| Operating Profit | 0.15 | 0.96 | 1.27 | 1.18 | 7.49 | 9.98 | 8.35 | 2.59 | -9.91 | 0.97 | 2.04 | 3.28 | 3.47 |
| OPM % | 5.22% | 4.63% | 21.70% | 52.83% | 13.44% | 3.19% | -26.91% | 4.92% | 5.95% | 11.98% | 16.01% | ||
| Other Income | 0.01 | 0.01 | 0.02 | 0.26 | 0.47 | 0.62 | 0.11 | 0.14 | 0.06 | 0.03 | 0.35 | 0.40 | 0.40 |
| Interest | 0.09 | 0.89 | 0.47 | 0.41 | 5.54 | 7.99 | 6.47 | 1.99 | 0.45 | 0.21 | 0.57 | 1.13 | 1.96 |
| Depreciation | 0.02 | 0.08 | 0.09 | 0.34 | 0.82 | 0.76 | 0.75 | 0.73 | 0.71 | 0.71 | 0.68 | 0.58 | 0.51 |
| Profit before tax | 0.05 | 0.00 | 0.73 | 0.69 | 1.60 | 1.85 | 1.24 | 0.01 | -11.01 | 0.08 | 1.14 | 1.97 | 1.40 |
| Tax % | 40.00% | 30.14% | 47.83% | 30.00% | 29.19% | 33.87% | -100.00% | -0.09% | -37.50% | -2.63% | -1.52% | ||
| Net Profit | 0.02 | 0.02 | 0.51 | 0.37 | 1.12 | 1.32 | 0.82 | 0.02 | -11.00 | 0.11 | 1.18 | 1.99 | 1.41 |
| EPS in Rs | 20.00 | 20.00 | 1.28 | 0.49 | 1.47 | 1.08 | 0.33 | 0.01 | -4.41 | 0.04 | 0.47 | 0.80 | 0.56 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 2450.00% | -27.45% | 202.70% | 17.86% | -37.88% | -97.56% | -55100.00% | 101.00% | 972.73% | 68.64% |
| Change in YoY Net Profit Growth (%) | 0.00% | 2450.00% | -2477.45% | 230.15% | -184.85% | -55.74% | -59.68% | -55002.44% | 55201.00% | 871.73% | -904.08% |
Art Nirman Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -15% |
| 3 Years: | -9% |
| TTM: | -32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 58% |
| 5 Years: | 19% |
| 3 Years: | 30% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -22% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -4% |
| 3 Years: | 3% |
| Last Year: | 5% |
Last Updated: September 4, 2025, 11:35 pm
Balance Sheet
Last Updated: December 10, 2025, 2:23 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 4.00 | 7.60 | 7.60 | 12.18 | 24.96 | 24.96 | 24.96 | 24.96 | 24.96 | 24.96 | 24.96 |
| Reserves | 0.01 | 0.03 | 0.51 | 6.28 | 7.40 | 16.65 | 20.02 | 20.04 | 9.05 | 9.16 | 10.34 | 12.33 | 12.69 |
| Borrowings | 6.11 | 12.15 | 2.14 | 17.85 | 62.17 | 50.13 | 33.76 | 4.95 | 0.23 | 2.53 | 2.92 | 18.06 | 19.83 |
| Other Liabilities | 5.96 | 11.93 | 11.52 | 43.06 | 33.69 | 75.44 | 59.38 | 13.26 | 10.74 | 15.23 | 14.96 | 13.46 | 30.64 |
| Total Liabilities | 12.09 | 24.12 | 18.17 | 74.79 | 110.86 | 154.40 | 138.12 | 63.21 | 44.98 | 51.88 | 53.18 | 68.81 | 88.12 |
| Fixed Assets | 0.67 | 0.61 | 0.71 | 9.72 | 9.16 | 8.62 | 7.87 | 7.18 | 6.48 | 5.78 | 5.11 | 4.56 | 4.33 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 0.32 | 0.34 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 11.42 | 23.51 | 17.46 | 65.07 | 101.70 | 145.48 | 129.93 | 55.69 | 38.18 | 46.10 | 48.07 | 64.25 | 83.79 |
| Total Assets | 12.09 | 24.12 | 18.17 | 74.79 | 110.86 | 154.40 | 138.12 | 63.21 | 44.98 | 51.88 | 53.18 | 68.81 | 88.12 |
Below is a detailed analysis of the balance sheet data for Art Nirman Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 24.96 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 24.96 Cr..
- For Reserves, as of Sep 2025, the value is 12.69 Cr.. The value appears strong and on an upward trend. It has increased from 12.33 Cr. (Mar 2025) to 12.69 Cr., marking an increase of 0.36 Cr..
- For Borrowings, as of Sep 2025, the value is 19.83 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 18.06 Cr. (Mar 2025) to 19.83 Cr., marking an increase of 1.77 Cr..
- For Other Liabilities, as of Sep 2025, the value is 30.64 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.46 Cr. (Mar 2025) to 30.64 Cr., marking an increase of 17.18 Cr..
- For Total Liabilities, as of Sep 2025, the value is 88.12 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 68.81 Cr. (Mar 2025) to 88.12 Cr., marking an increase of 19.31 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4.33 Cr.. The value appears to be declining and may need further review. It has decreased from 4.56 Cr. (Mar 2025) to 4.33 Cr., marking a decrease of 0.23 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 83.79 Cr.. The value appears strong and on an upward trend. It has increased from 64.25 Cr. (Mar 2025) to 83.79 Cr., marking an increase of 19.54 Cr..
- For Total Assets, as of Sep 2025, the value is 88.12 Cr.. The value appears strong and on an upward trend. It has increased from 68.81 Cr. (Mar 2025) to 88.12 Cr., marking an increase of 19.31 Cr..
However, the Borrowings (19.83 Cr.) are higher than the Reserves (12.69 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.96 | -11.19 | -0.87 | -16.67 | -54.68 | -40.15 | -25.41 | -2.36 | -10.14 | -1.56 | -0.88 | -14.78 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 109.10 | 200.74 | 470.50 | 122.80 | 63.57 | 177.99 | 425.90 | 35.34 | 33.18 | ||
| Inventory Days | 342.64 | 1,255.58 | 2,907.50 | 1,108.74 | 168.71 | 82.59 | 581.00 | 356.24 | ||||
| Days Payable | 21.05 | 215.31 | 380.83 | 104.99 | 17.78 | 15.86 | 272.84 | 125.95 | ||||
| Cash Conversion Cycle | 321.59 | 1,149.36 | 2,727.41 | 470.50 | 1,126.55 | 214.50 | 244.73 | 734.05 | 265.63 | 33.18 | ||
| Working Capital Days | 129.27 | 672.66 | 605.72 | 935.20 | 371.35 | 206.46 | 269.66 | 641.16 | 322.32 | 646.31 | ||
| ROCE % | 3.55% | 9.72% | 12.74% | 5.73% | 13.11% | 12.60% | 9.78% | 3.11% | -25.09% | 0.82% | 4.49% | 6.63% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.80 | 0.47 | 0.04 | -4.41 | 0.01 |
| Diluted EPS (Rs.) | 0.80 | 0.47 | 0.04 | -4.41 | 0.01 |
| Cash EPS (Rs.) | 1.03 | 0.74 | 0.32 | -4.12 | 0.29 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.94 | 14.14 | 13.67 | 13.63 | 18.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.94 | 14.14 | 13.67 | 13.63 | 18.03 |
| Revenue From Operations / Share (Rs.) | 10.97 | 13.74 | 7.90 | 14.76 | 34.08 |
| PBDIT / Share (Rs.) | 1.47 | 0.95 | 0.40 | -3.94 | 1.09 |
| PBIT / Share (Rs.) | 1.24 | 0.68 | 0.11 | -4.23 | 0.80 |
| PBT / Share (Rs.) | 0.78 | 0.45 | 0.03 | -4.41 | 0.00 |
| Net Profit / Share (Rs.) | 0.79 | 0.47 | 0.04 | -4.41 | 0.01 |
| PBDIT Margin (%) | 13.42 | 6.98 | 5.06 | -26.72 | 3.20 |
| PBIT Margin (%) | 11.28 | 5.00 | 1.47 | -28.66 | 2.35 |
| PBT Margin (%) | 7.17 | 3.34 | 0.42 | -29.89 | 0.01 |
| Net Profit Margin (%) | 7.27 | 3.43 | 0.56 | -29.86 | 0.02 |
| Return on Networth / Equity (%) | 5.34 | 3.33 | 0.32 | -32.34 | 0.04 |
| Return on Capital Employeed (%) | 5.38 | 4.13 | 0.70 | -26.62 | 3.64 |
| Return On Assets (%) | 2.89 | 2.21 | 0.21 | -24.44 | 0.03 |
| Long Term Debt / Equity (X) | 0.48 | 0.08 | 0.07 | 0.00 | 0.10 |
| Total Debt / Equity (X) | 0.48 | 0.08 | 0.07 | 0.01 | 0.11 |
| Asset Turnover Ratio (%) | 0.44 | 0.65 | 0.40 | 0.68 | 0.84 |
| Current Ratio (X) | 5.57 | 3.99 | 4.26 | 7.08 | 6.65 |
| Quick Ratio (X) | 1.88 | 2.34 | 2.92 | 5.53 | 2.66 |
| Inventory Turnover Ratio (X) | 0.89 | 2.05 | 1.24 | 0.55 | 0.08 |
| Interest Coverage Ratio (X) | 3.26 | 4.19 | 4.82 | -21.79 | 1.37 |
| Interest Coverage Ratio (Post Tax) (X) | 2.77 | 3.06 | 1.54 | -23.35 | 1.01 |
| Enterprise Value (Cr.) | 121.61 | 122.85 | 128.86 | 237.15 | 83.72 |
| EV / Net Operating Revenue (X) | 4.44 | 3.58 | 6.54 | 6.44 | 0.98 |
| EV / EBITDA (X) | 33.09 | 51.32 | 128.91 | -24.09 | 30.73 |
| MarketCap / Net Operating Revenue (X) | 3.92 | 3.62 | 6.42 | 6.57 | 0.93 |
| Price / BV (X) | 2.88 | 3.52 | 3.71 | 7.12 | 1.77 |
| Price / Net Operating Revenue (X) | 3.92 | 3.62 | 6.42 | 6.57 | 0.93 |
| EarningsYield | 0.01 | 0.01 | 0.00 | -0.04 | 0.00 |
After reviewing the key financial ratios for Art Nirman Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.80. This value is below the healthy minimum of 5. It has increased from 0.47 (Mar 24) to 0.80, marking an increase of 0.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.80. This value is below the healthy minimum of 5. It has increased from 0.47 (Mar 24) to 0.80, marking an increase of 0.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.03. This value is below the healthy minimum of 3. It has increased from 0.74 (Mar 24) to 1.03, marking an increase of 0.29.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.94. It has increased from 14.14 (Mar 24) to 14.94, marking an increase of 0.80.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.94. It has increased from 14.14 (Mar 24) to 14.94, marking an increase of 0.80.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 10.97. It has decreased from 13.74 (Mar 24) to 10.97, marking a decrease of 2.77.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 2. It has increased from 0.95 (Mar 24) to 1.47, marking an increase of 0.52.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 1.24, marking an increase of 0.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.78. This value is within the healthy range. It has increased from 0.45 (Mar 24) to 0.78, marking an increase of 0.33.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 2. It has increased from 0.47 (Mar 24) to 0.79, marking an increase of 0.32.
- For PBDIT Margin (%), as of Mar 25, the value is 13.42. This value is within the healthy range. It has increased from 6.98 (Mar 24) to 13.42, marking an increase of 6.44.
- For PBIT Margin (%), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from 5.00 (Mar 24) to 11.28, marking an increase of 6.28.
- For PBT Margin (%), as of Mar 25, the value is 7.17. This value is below the healthy minimum of 10. It has increased from 3.34 (Mar 24) to 7.17, marking an increase of 3.83.
- For Net Profit Margin (%), as of Mar 25, the value is 7.27. This value is within the healthy range. It has increased from 3.43 (Mar 24) to 7.27, marking an increase of 3.84.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.34. This value is below the healthy minimum of 15. It has increased from 3.33 (Mar 24) to 5.34, marking an increase of 2.01.
- For Return on Capital Employeed (%), as of Mar 25, the value is 5.38. This value is below the healthy minimum of 10. It has increased from 4.13 (Mar 24) to 5.38, marking an increase of 1.25.
- For Return On Assets (%), as of Mar 25, the value is 2.89. This value is below the healthy minimum of 5. It has increased from 2.21 (Mar 24) to 2.89, marking an increase of 0.68.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. It has increased from 0.08 (Mar 24) to 0.48, marking an increase of 0.40.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. It has increased from 0.08 (Mar 24) to 0.48, marking an increase of 0.40.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.44. It has decreased from 0.65 (Mar 24) to 0.44, marking a decrease of 0.21.
- For Current Ratio (X), as of Mar 25, the value is 5.57. This value exceeds the healthy maximum of 3. It has increased from 3.99 (Mar 24) to 5.57, marking an increase of 1.58.
- For Quick Ratio (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 1.88, marking a decrease of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 4. It has decreased from 2.05 (Mar 24) to 0.89, marking a decrease of 1.16.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.26. This value is within the healthy range. It has decreased from 4.19 (Mar 24) to 3.26, marking a decrease of 0.93.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 3. It has decreased from 3.06 (Mar 24) to 2.77, marking a decrease of 0.29.
- For Enterprise Value (Cr.), as of Mar 25, the value is 121.61. It has decreased from 122.85 (Mar 24) to 121.61, marking a decrease of 1.24.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.44. This value exceeds the healthy maximum of 3. It has increased from 3.58 (Mar 24) to 4.44, marking an increase of 0.86.
- For EV / EBITDA (X), as of Mar 25, the value is 33.09. This value exceeds the healthy maximum of 15. It has decreased from 51.32 (Mar 24) to 33.09, marking a decrease of 18.23.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.92. This value exceeds the healthy maximum of 3. It has increased from 3.62 (Mar 24) to 3.92, marking an increase of 0.30.
- For Price / BV (X), as of Mar 25, the value is 2.88. This value is within the healthy range. It has decreased from 3.52 (Mar 24) to 2.88, marking a decrease of 0.64.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.92. This value exceeds the healthy maximum of 3. It has increased from 3.62 (Mar 24) to 3.92, marking an increase of 0.30.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Art Nirman Ltd:
- Net Profit Margin: 7.27%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.38% (Industry Average ROCE: 12.09%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.34% (Industry Average ROE: 10.71%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.77
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.88
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 76.1 (Industry average Stock P/E: 51.91)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.27%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Project Consultancy/Turnkey | 410, JBR Arcade, Science City Road, Ahmedabad Gujarat 380060 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashokkumar Thakker | Chairman & Managing Director |
| Mr. Piyush Thakkar | Executive Director |
| Mrs. Dharmishthaben Thakkar | Non Executive Director |
| Mr. Krunal Mistry | Independent Director |
| Mr. Hemang Shah | Independent Director |
| Mr. Chintan Bhatt | Independent Director |
FAQ
What is the intrinsic value of Art Nirman Ltd?
Art Nirman Ltd's intrinsic value (as of 11 February 2026) is ₹73.45 which is 70.81% higher the current market price of ₹43.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹107 Cr. market cap, FY2025-2026 high/low of ₹72.5/39.7, reserves of ₹12.69 Cr, and liabilities of ₹88.12 Cr.
What is the Market Cap of Art Nirman Ltd?
The Market Cap of Art Nirman Ltd is 107 Cr..
What is the current Stock Price of Art Nirman Ltd as on 11 February 2026?
The current stock price of Art Nirman Ltd as on 11 February 2026 is ₹43.0.
What is the High / Low of Art Nirman Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Art Nirman Ltd stocks is ₹72.5/39.7.
What is the Stock P/E of Art Nirman Ltd?
The Stock P/E of Art Nirman Ltd is 76.1.
What is the Book Value of Art Nirman Ltd?
The Book Value of Art Nirman Ltd is 15.1.
What is the Dividend Yield of Art Nirman Ltd?
The Dividend Yield of Art Nirman Ltd is 0.00 %.
What is the ROCE of Art Nirman Ltd?
The ROCE of Art Nirman Ltd is 6.63 %.
What is the ROE of Art Nirman Ltd?
The ROE of Art Nirman Ltd is 5.48 %.
What is the Face Value of Art Nirman Ltd?
The Face Value of Art Nirman Ltd is 10.0.